Loading
Latest filing published 12 May 2026 for LAKEFRONT BIOTHERAPEUTICS, €76k. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Gosebruch Henry on record concern Lakefront Biotherapeutics. We count 4 filings; the first trade dates from 12 June 2025 and the latest from 11 May 2026.
No open-market sale appears; the market trades are 4 purchases worth €235k. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 3 purchases and no sales.
On 12 May 2026 came the latest disclosure, an open-market purchase for €76k in Lakefront Biotherapeutics. Typically, a trade is published a median of 5 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by FSMA and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations